| Name | Title | Contact Details |
|---|
Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Headquartered in Shanghai since our founding in 2014, our experienced team has secured partnerships with leading global biopharma companies, generating a broad and late-stage pipeline of innovative drug candidates. Based on our extensive track record of execution and delivering results, Zai Lab has earned the reputation as a trusted partner of choice for global biopharmaceutical companies seeking to not only access the Chinese market but also find a long-term strategic partner for global clinical development. Through these partnerships, Zai Lab has built the strongest late stage oncology portfolio with global first-in-class and/or best-in-class profile, among innovative Chinese biotech companies. We are further supplementing our pipeline with an in-house discovery effort aiming to produce 1-2 global INDs per year. Zai Lab is rapidly expanding into a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing innovative medicines. To that end, we have built our internal R&D center to advance our discovery pipeline, a strong clinical development and operations team, and our own manufacturing facilities in China. We have also established a highly specialized commercial team to support marketing of our innovative products in China. We believe this integrated approach will provide sustainable competitive advantages for Zai Lab. Zai Lab was successfully listed on the Nasdaq Stock Market in September 2017. Since then, Zai Lab significantly expanded with several offices across China and opened its U.S. headquarters in San Francisco in December 2018. As of December 2019, the Company has a global team of approximately 700 employees.
Laboratoires Pro Doc Ltee is a Laval, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nelson Laboratories has served the medical device and pharmaceutical industry since 1985. We maintain our belief that we can serve the industry best by providing a quality facility and a staff devoted to quality and customer service. Our continued growth
NovaSom is a privately held diagnostic-service provider for home testing and evaluation of obstructive sleep apnea (OSA). As an innovator and pioneer in our field, we developed the first FDA-cleared device designed for unattended, unassisted patient use for the diagnosis of sleep apnea, with clinically proven equivalence * to conventional polysomnography (PSG). NovaSom works with physicians, private insurers, government and public health organizations to address concerns about the large numbers of individuals with undiagnosed sleep apnea. It is our shared concern that millions of Americans are utilizing more health care resources and incurring greater health care costs because their OSA has not been properly diagnosed or treated. It is also our belief that early diagnosis and treatment of OSA can improve lives and help hold down health care costs. Our mission is to improve the health care and quality of life of those impacted by sleep disorders through innovative diagnostic services and by promoting adherence to prescribed therapies.
Cardinal Laboratories is a Crescent Springs, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.